Peter Petrow
Overview
Explore the profile of Peter Petrow including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
1644
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Maubec E, Boubaya M, Petrow P, Beylot-Barry M, Basset-Seguin N, Deschamps L, et al.
J Clin Oncol
. 2020 Jul;
38(26):3051-3061.
PMID: 32730186
Purpose: To evaluate first-line pembrolizumab monotherapy efficacy and safety in patients with unresectable cutaneous squamous cell carcinomas (CSCCs). Patients And Methods: Patients, predominantly men, with their CSSCs' immunohistochemically determined programmed...
2.
De la Rochefordiere A, Kamal M, Floquet A, Thomas L, Petrow P, Petit T, et al.
Clin Cancer Res
. 2015 Mar;
21(11):2530-7.
PMID: 25724520
Purpose: EGFR is frequently overexpressed in cervical cancer, suggesting EGFR blockade as a promising treatment approach. Cetuximab, an anti EGFR antibody, used conjointly with radiochemotherapy, was feasible in first-line treatment...
3.
Campitelli M, Jeannot E, Peter M, Lappartient E, Saada S, De la Rochefordiere A, et al.
PLoS One
. 2012 Sep;
7(8):e43393.
PMID: 22937045
Introduction: In most cases of cervical cancers, HPV DNA is integrated into the genome of carcinoma cells. This mutational insertion constitutes a highly specific molecular marker of tumor DNA for...
4.
Marszalek A, Alran S, Scholl S, Fourchotte V, Plancher C, Rosty C, et al.
Int J Surg Oncol
. 2012 Feb;
2010:214919.
PMID: 22312486
Objectives. The purpose of this retrospective evaluation of advanced-stage ovarian cancer patients was to compare outcome with published findings from other centers and to discuss future options for the management...
5.
Dimopoulos J, Petrow P, Tanderup K, Petric P, Berger D, Kirisits C, et al.
Radiother Oncol
. 2012 Feb;
103(1):113-22.
PMID: 22296748
The GYN GEC-ESTRO working group issued three parts of recommendations and highlighted the pivotal role of MRI for the successful implementation of 3D image-based cervical cancer brachytherapy (BT). The main...
6.
De la Rochefordiere A, Kirova Y, Alran S, Plancher C, Fourchotte V, Beuzeboc P, et al.
Clin Med Oncol
. 2011 Sep;
2:227-36.
PMID: 21892284
Objective: To evaluate the treatment results of patients (pts) with FIGO stage IB2, IIA, IIB cervical carcinoma (CC) treated with pre-operative radio-chemotherapy, followed by extended radical hysterectomy. Methods: Retrospective study...
7.
Maubec E, Petrow P, Scheer-Senyarich I, Duvillard P, Lacroix L, Gelly J, et al.
J Clin Oncol
. 2011 Aug;
29(25):3419-26.
PMID: 21810686
Purpose: To evaluate the efficacy and safety of cetuximab, a monoclonal antibody that inhibits the epidermal growth factor receptor (EGFR), as a first-line monotherapy in patients with unresectable squamous cell...
8.
Bidault F, Vanel D, Athanasiou A, Pigneur F, Lopez I, Petrow P, et al.
Bull Cancer
. 2006 Dec;
93(12):1167-74.
PMID: 17182372
Retroperitoneal sarcomas are rare neoplasms. The aim of this article is to expose imaging protocols and useful radiological signs, to show the core biopsy technique for diagnosis, to precise imaging...
9.
Lang S, Nulens A, Briot E, Kirisits C, De Brabandere M, Dumas I, et al.
Radiother Oncol
. 2006 Feb;
78(2):185-93.
PMID: 16466820
Purpose: To perform a multicentre intercomparison study of treatment concepts for MRI assisted brachytherapy of cervix cancer based on recommendations of the Gynaecological GEC-ESTRO Working Group. Methods: Each participating centre...
10.
Potter R, Haie-Meder C, Van Limbergen E, Barillot I, De Brabandere M, Dimopoulos J, et al.
Radiother Oncol
. 2006 Jan;
78(1):67-77.
PMID: 16403584
The second part of the GYN GEC ESTRO working group recommendations is focused on 3D dose-volume parameters for brachytherapy of cervical carcinoma. Methods and parameters have been developed and validated...